GUIDED THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Guided Therapeutics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Guided Therapeutics Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $164K, a 33.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $164K -$83K -33.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $185K -$81K -30.5% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $207K -$78K -27.4% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $227K -$76K -25.1% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $247K -$74K -23.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $266K -$72K -21.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $285K -$70K -19.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $303K -$69K -18.5% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $321K -$67K -17.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $338K -$65K -16.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $355K -$71K -16.7% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $372K -$81K -17.9% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $388K +$327K +536% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $403K +$317K +369% Jun 30, 2021 10-Q 2021-08-18
Q1 2021 $426K +$317K +291% Mar 31, 2021 10-Q/A 2021-08-18
Q4 2020 $453K +$321K +243% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $61K -$92K -60.1% Sep 30, 2020 10-Q/A 2020-11-05
Q2 2020 $86K -$89K -50.9% Jun 30, 2020 10-Q 2020-08-20
Q1 2020 $109K -$93K -46% Mar 31, 2020 10-Q 2020-07-07
Q4 2019 $132K +$132K Dec 31, 2019 10-K 2021-04-07
Q3 2019 $153K Sep 30, 2019 10-Q 2020-03-09
Q2 2019 $175K Jun 30, 2019 10-Q 2020-02-11
Q1 2019 $202K Mar 31, 2019 10-Q 2019-07-11
Q4 2018 $0 Dec 31, 2018 10-K 2020-04-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.